fluconazole has been researched along with deoxycholic acid in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (6.38) | 18.2507 |
| 2000's | 13 (27.66) | 29.6817 |
| 2010's | 22 (46.81) | 24.3611 |
| 2020's | 9 (19.15) | 2.80 |
| Authors | Studies |
|---|---|
| Bakker-Woudenberg, IA; van den Heuvel-de Groot, C; van Etten, EW | 1 |
| de Pauw, BE; Meunier, F | 1 |
| Carrillo-Muñoz, AJ; Cossum, PA; del Valle, O; Miranda, Y; Quindós, G; Ruesga, MT; Tur, C; Wallace, TL | 1 |
| Chandrasekar, PH | 1 |
| Paterson, DL; Singh, N | 1 |
| Wingard, JR | 1 |
| Avorn, J; Fischer, MA; Rubin, RH; Winkelmayer, WC | 1 |
| Leather, H; Wingard, JR | 1 |
| de Górgolas, M; Erice, A; Gil, A; Gutiérrez, J; Hernando, C; Rivas, P; Rodríguez, MC | 1 |
| Benjamin, DK; Smith, PB; Tiffany, KF | 1 |
| Bicanic, T; Brouwer, AE; Harrison, TS; Macallan, DC; Macsween, KF; Marsh, H | 1 |
| Marik, PE | 1 |
| Pemán, J; Zaragoza, R | 1 |
| Caron, F; Etienne, M | 1 |
| Hollenbach, E | 1 |
| Menezes, Y; Muller, RP; Pádua, SS; Park, MV; Passos, RM; Pereira, GH | 1 |
| Corti, M; Negroni, R; Yampolsky, C | 1 |
| Lazzaro, C | 1 |
| Celebi, S; Hacimustafaoglu, M | 1 |
| Ascher, SB; Benjamin, DK; Clark, RH; Cohen-Wolkowiez, M; Moran, C; Smith, PB; Watt, K | 1 |
| Chakrabarti, A; Jatana, M; Rudramurthy, SM; Singh, R | 1 |
| Bocanegra, R; Kirkpatrick, WR; Najvar, LK; Patterson, TF; Sorrell, TC; Wiederhold, NP | 1 |
| Dreyfuss, D; Gaudry, S; Ricard, JD | 1 |
| Benjamin, DK; Ericson, J; Manzoni, P | 1 |
| Nicolle, LE | 1 |
| Abbasi, K; Anvari, MS; Badali, H; Boroumand, M; Fesharaki, SH; Haghani, I; Kargar, ML; Meis, JF; Mousavi, B | 1 |
| Alvarado-Matute, T; Colombo, AL; Cornejo-Juarez, P; Cortes, J; Corzo-Leon, DE; Echevarria, JI; Guzman-Blanco, M; Macias, AE; Nucci, M; Ostrosky-Zeichner, L; Ponce-de-Leon, A; Queiroz-Telles, F; Santolaya, ME; Sifuentes-Osornio, J; Thompson-Moya, L; Tiraboschi, IN; Zurita, J | 1 |
| Bielicki, J; Doerholt, K; Goossens, H; Lestner, JM; Roilides, E; Sharland, M; Versporten, A; Warris, A | 1 |
| Monk, HM; Wade, KC | 1 |
| Boulware, DR; Merry, M | 1 |
| Bustamante, B; Concha-Velasco, F; González-Lagos, E; Seas, C | 1 |
| Almeida-Paes, R; Carregal, E; Gonçalves, MLC; Gutierrez Galhardo, MC; Lamas, CDC; Lemos, AS; Lima, MASD; Moreira, JA; Oliveira, MME; Valviesse, VRGA; Zancopé Oliveira, RM | 1 |
| Harrison, TS; Ming, DK | 1 |
| Lehrnbecher, T; Schmidt, S; Schubert, R; Tramsen, L | 1 |
| Eshun-Wilson, I; Ford, N; Garner, P; Migone, C | 1 |
| Cortés, J; Kral, A; Wilson, G | 1 |
| Bay, MB; de Oliveira, AL; Freire, MG; Gomes, RMODS; Soares, RDA; Theodoro, RC; Vechi, HT | 1 |
| Chong, Y; Jie, Y; Li, X; Li, Z; Liu, Y; Yan, Y; Zheng, X | 1 |
| Boulware, DR; Evans, EE; Meya, DB; Muzoora, C; Nalintya, E; Ndyetukira, JF; Nuwagira, E; Pastick, KA; Rajasingham, R; Rhein, J; Skipper, C; Ssebambulidde, K; Stephens, N; Tugume, L | 1 |
| Hine, P; Murray, M | 1 |
| Byun, JH; Choi, JH; Chun, HS; Han, EH; Jeong, Y; Kim, SH; Kim, YJ; Lee, SO; Park, C; Song, KY | 1 |
| Croitor-Sava, AR; Hillen, A; Himmelreich, U; Lagrou, K; Poelmans, J; Sorrell, TC; Vande Velde, G; Vanherp, L; Weerasekera, A | 1 |
| Boulware, DR; de Albuquerque Moraes, C; de Oliveira, ACP; de Siqueira, REB; Marcusso, R; Miranda, NFB; Vidal, JE | 1 |
| Alufandika, M; Bicanic, T; Day, JN; Harrison, TS; Hope, W; Jarvis, JN; Lalloo, DG; Loyse, A; Mwandumba, HC; Perfect, JR; Stott, KE | 1 |
| Ashley, EA; Macrae, C; McLean, ARD; Smithuis, F; Tun, NN; Warrell, CE; Wilkins, E | 1 |
| Chen, Y; Harypursat, V; Lan, K; Lu, Y; Wu, Y; Xu, X; Yang, T; Yu, J; Zeng, Q; Zhang, W; Zhao, T; Zhou, G | 1 |
| Gonçalves, GA; Kraft, L; Ribeiro, VST; Suss, PH; Tuon, FF | 1 |
15 review(s) available for fluconazole and deoxycholic acid
| Article | Year |
|---|---|
The challenge of invasive fungal infection.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Deoxycholic Acid; Drug Combinations; Fluconazole; Flucytosine; Fungemia; Histoplasmosis; Humans; Immunocompromised Host; Mycoses; Zygomycosis | 1999 |
Empirical antifungal therapy in treating febrile neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Deoxycholic Acid; Drug Combinations; Fever; Fluconazole; Fungemia; Humans; Immunocompromised Host; Neutropenia; Opportunistic Infections | 2004 |
Neonatal candidiasis: prophylaxis and treatment.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Infant, Low Birth Weight; Infant, Newborn; Randomized Controlled Trials as Topic; Risk Factors | 2005 |
Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid Pressure; Cryptococcus neoformans; Deoxycholic Acid; Drainage; Drug Combinations; Female; Fluconazole; Flucytosine; HIV-1; Humans; Meningitis, Cryptococcal; Spinal Puncture; Treatment Outcome | 2005 |
Fungal infections in solid organ transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Deoxycholic Acid; Drug Combinations; Echinocandins; Fluconazole; Humans; Incidence; Lipopeptides; Organ Transplantation; Peptides, Cyclic; Postoperative Complications; Premedication | 2006 |
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
[Management of fungal urinary tract infections].
Topics: Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Cystitis; Deoxycholic Acid; Drug Combinations; Female; Fluconazole; Fungemia; Fungi; Health Status; Hospital Mortality; Humans; Male; Mycoses; Primary Prevention; Pyelonephritis; Risk Factors; Urinary Catheterization; Urinary Tract Infections; Urine | 2007 |
Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Intensive Care Units; Itraconazole; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2008 |
Candida infections in non-neutropenic children after the neonatal period.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Catheter-Related Infections; Child; Cross Infection; Deoxycholic Acid; Drug Combinations; Echinocandins; Fluconazole; Flucytosine; Humans; Infant, Newborn; Intensive Care Units; Leukocyte Count; Mycological Typing Techniques; Neutrophils; Survival Rate; United States | 2011 |
Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Echinocandins; Fluconazole; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Neonatology; Pyrimidines; Triazoles; Voriconazole | 2013 |
Urinary tract infection.
Topics: Acute Disease; Aminoglycosides; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Catheters, Indwelling; Community-Acquired Infections; Cross Infection; Deoxycholic Acid; Drug Combinations; Female; Fluconazole; Humans; Male; Prognosis; Risk Factors; Shock, Septic; Urinary Tract; Urinary Tract Infections | 2013 |
New antifungal and antiviral dosing.
Topics: Acyclovir; Amphotericin B; Antifungal Agents; Antiviral Agents; Candidiasis, Invasive; Cytomegalovirus Infections; Deoxycholic Acid; Drug Combinations; Fluconazole; Ganciclovir; Herpes Simplex; Humans; Infant; Infant, Newborn; Mycoses; Practice Guidelines as Topic; Pregnancy Complications, Infectious; Valganciclovir; Virus Diseases | 2015 |
Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Cryptococcus neoformans; Deoxycholic Acid; Disease Management; Drug Combinations; Female; Fluconazole; HIV Infections; Humans; Meningitis, Cryptococcal; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Uganda; Young Adult | 2020 |
Treating progressive disseminated histoplasmosis in people living with HIV.
Topics: Amphotericin B; Anti-HIV Agents; Antifungal Agents; Cohort Studies; Deoxycholic Acid; Drug Administration Schedule; Fluconazole; Histoplasmosis; HIV Infections; Humans; Induction Chemotherapy; Itraconazole; Kidney; Liposomes; Maintenance Chemotherapy; Randomized Controlled Trials as Topic | 2020 |
Cryptococcal meningoencephalitis: time for action.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Databases, Factual; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Meningoencephalitis | 2021 |
1 trial(s) available for fluconazole and deoxycholic acid
| Article | Year |
|---|---|
[Economic evaluation of posaconazole in prophylaxis of invasive fungal infections in Italian neutropenic patients with acute myeloid leukaemia or myelodysplastic syndrome].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Drug Costs; Equipment and Supplies; Fluconazole; Follow-Up Studies; Hospital Costs; Humans; Immunocompromised Host; Infusions, Intravenous; Italy; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Neutropenia; Oncology Nursing; Treatment Outcome; Triazoles | 2010 |
31 other study(ies) available for fluconazole and deoxycholic acid
| Article | Year |
|---|---|
Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice.
Topics: Amphotericin B; Animals; Candidiasis; Deoxycholic Acid; Drug Carriers; Drug Combinations; Female; Fluconazole; Immunocompetence; Leukopenia; Liposomes; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests | 1993 |
In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Deoxycholic Acid; Drug Carriers; Drug Combinations; Fluconazole; Humans; Itraconazole; Liposomes; Microbial Sensitivity Tests; Nystatin; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
Empirical antifungal therapy for persistent fever in patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Deoxycholic Acid; Drug Combinations; Fever; Fluconazole; Humans; Mycoses; Neutropenia | 2001 |
Cryptococcus neoformans infection.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunosuppressive Agents; Organ Transplantation | 2002 |
The hepatotoxicity of antifungal medications in bone marrow transplant recipients.
Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Case-Control Studies; Chemical and Drug Induced Liver Injury; Deoxycholic Acid; Drug Combinations; Female; Fluconazole; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Phosphatidylcholines; Phosphatidylglycerols; Risk Factors | 2005 |
Hepatotoxicity associated with antifungal therapy after bone marrow transplantation.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Phosphatidylcholines; Phosphatidylglycerols; Risk Factors | 2005 |
Cryptococcal meningitis in a patient with X-linked hyper-IgM1 syndrome.
Topics: Adult; Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Fluconazole; Genetic Diseases, X-Linked; Humans; Hypergammaglobulinemia; Immunoglobulin M; Male; Meningitis, Cryptococcal | 2005 |
Chronic meningitis by histoplasmosis: report of a child with acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Amphotericin B; Antifungal Agents; Chronic Disease; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Histoplasmosis; Humans; Immunocompromised Host; Leukemia, Myeloid; Male; Meningitis, Fungal; Treatment Outcome | 2008 |
Fungal cerebral abscess in a diabetic patient successfully treated with surgery followed by prolonged antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Brain Abscess; Candida albicans; Candidiasis; Combined Modality Therapy; Craniotomy; Deoxycholic Acid; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Fluconazole; Humans; Hyphae; Magnetic Resonance Imaging; Male; Mannitol; Middle Aged; Parietal Lobe; Psoas Abscess | 2010 |
Antifungal therapy and outcomes in infants with invasive Candida infections.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Invasive; Deoxycholic Acid; Drug Combinations; Female; Fluconazole; Humans; Infant; Infant Mortality; Infant, Newborn; Intensive Care Units, Neonatal; Logistic Models; Male; Treatment Outcome; United States | 2012 |
In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2013 |
Limited activity of miltefosine in murine models of cryptococcal meningoencephalitis and disseminated cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Deoxycholic Acid; Drug Combinations; Fluconazole; Meningitis, Cryptococcal; Meningoencephalitis; Mice; Microbial Sensitivity Tests; Phosphorylcholine; Survival | 2013 |
Amphotericin B deoxycholate for candidiasis in intensive care unit patients revisited: medical, ethical, and financial implications.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Creatinine; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Practice Patterns, Physicians'; Renal Insufficiency | 2013 |
Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candida tropicalis; Candidiasis; Coinfection; Deoxycholic Acid; DNA, Fungal; DNA, Ribosomal Spacer; Drug Combinations; Drug Users; Echocardiography; Endocarditis; Fatal Outcome; Fluconazole; Humans; Male; Molecular Sequence Data; Mycological Typing Techniques; Sequence Analysis, DNA; Substance-Related Disorders; Tricuspid Valve | 2013 |
Surveillance of Candida spp bloodstream infections: epidemiological trends and risk factors of death in two Mexican tertiary care hospitals.
Topics: Adult; Aged; Amphotericin B; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Deoxycholic Acid; Drug Combinations; Female; Fluconazole; Humans; Incidence; Male; Mexico; Middle Aged; Proportional Hazards Models; Prospective Studies; Regression Analysis; Risk Factors; Tertiary Care Centers; Treatment Outcome | 2014 |
Systemic antifungal prescribing in neonates and children: outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) Study.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Deoxycholic Acid; Drug Combinations; Fluconazole; Hospitals; Humans; Infant; Infant, Newborn | 2015 |
Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Fluconazole; Flucytosine; Humans; Meningitis, Cryptococcal; United States | 2016 |
Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Colony Count, Microbial; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Female; Fluconazole; HIV Infections; Humans; Immunocompromised Host; Male; Meningitis, Cryptococcal; Retrospective Studies; Risk Factors; Treatment Outcome | 2017 |
Fungemia associated with Schizophyllum commune in Brazil.
Topics: Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Fluconazole; Fungemia; Humans; Male; Middle Aged; Schizophyllum | 2017 |
Cryptococcal meningitis.
Topics: Amphotericin B; Antifungal Agents; Brain; Cryptococcus gattii; Cryptococcus neoformans; Deoxycholic Acid; Diagnosis, Differential; Drug Combinations; Early Diagnosis; Fluconazole; HIV Infections; Humans; Immunocompromised Host; Meningitis, Cryptococcal; Patient Care Management | 2017 |
Impact of Antifungal Compounds on Viability and Anti-
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Cell Survival; Deoxycholic Acid; Doxorubicin; Drug Combinations; Fluconazole; Humans; Killer Cells, Natural; Microbial Sensitivity Tests; Polyethylene Glycols; Triazoles; Voriconazole | 2019 |
Updating guidance for preventing and treating cryptococcal disease: how evidence and decisions interface.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antigens, Fungal; Child; Cryptococcus; Deoxycholic Acid; Drug Combinations; Fluconazole; Flucytosine; HIV Infections; Humans; Maintenance Chemotherapy; Meningitis, Cryptococcal; Practice Guidelines as Topic; World Health Organization | 2018 |
[Cryptococcosis in Hospital Carlos Van Buren, Valparaiso: a clinical serie].
Topics: Adult; CD4-Positive T-Lymphocytes; Chile; Cryptococcosis; Cryptococcus neoformans; Deoxycholic Acid; Female; Fluconazole; Humans; Male; Retrospective Studies | 2018 |
Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.
Topics: Acute Kidney Injury; Amphotericin B; Antifungal Agents; Bone Marrow; CD4-Positive T-Lymphocytes; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Deoxycholic Acid; Diagnosis, Differential; Drug Combinations; Fluconazole; Genotype; HIV Infections; Humans; Male; Meningitis; Middle Aged | 2019 |
Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcus; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Immunocompetence; Male; Meningitis, Cryptococcal; Middle Aged; Organ Transplantation; Retrospective Studies; Treatment Outcome | 2019 |
Fungal arthritis with adjacent osteomyelitis caused by Candida pelliculosa: a case report.
Topics: Aged; Amphotericin B; Antifungal Agents; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Candida; Candidemia; Candidiasis; Deoxycholic Acid; Device Removal; Drug Combinations; Female; Fluconazole; Humans; Intraoperative Care; Joint Prosthesis; Knee; Micafungin; Osteomyelitis | 2020 |
Trehalose as quantitative biomarker for in vivo diagnosis and treatment follow-up in cryptococcomas.
Topics: Amphotericin B; Animals; Biomarkers; Cryptococcus neoformans; Deoxycholic Acid; Drug Combinations; Female; Fluconazole; Humans; Meningitis, Cryptococcal; Mice; Middle Aged; Trehalose | 2021 |
HIV-Associated Cryptococcal Meningitis Patients Treated with Amphotericin B Deoxycholate Plus Flucytosine under Routine Care Conditions in a Referral Center in São Paulo, Brazil.
Topics: Adult; Amphotericin B; Antifungal Agents; Brazil; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Male; Meningitis, Cryptococcal; Referral and Consultation; Retrospective Studies | 2021 |
Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Female; Fluconazole; HIV; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Myanmar; Phlebitis; Primary Health Care; Retrospective Studies; Treatment Outcome; Young Adult | 2021 |
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China.
Topics: Amphotericin B; Antifungal Agents; Cohort Studies; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Infertility; Meningitis, Cryptococcal; Prospective Studies; Voriconazole | 2022 |
Comparison of amphotericin B lipid complex, deoxycholate amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidemia.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candida albicans; Candidemia; Deoxycholic Acid; Fluconazole; Humans | 2023 |